Vaccination Against Pneumonia May Provide Genotype-Specific Protection Against Alzheimer's Disease

Area of Science:

• Neuroscience
• Immunology
• Genetics

Background:

• Alzheimer's disease (AD) prevention strategies are needed, with potential for vaccine repurposing.
• Individual genetic profiles, like the NECTIN2 rs6859 polymorphism, may influence AD risk.
• Investigating vaccine associations with AD onset in older adults is crucial.

Discussion:

• This study explored the link between vaccinations (pneumococcal polysaccharide vaccine, flu shots) and AD onset in individuals aged 65-75.
• The analysis considered the NECTIN2 rs6859 polymorphism, an identified AD risk factor.
• Associations were evaluated for AD onset at age 75 or older.

Key Insights:

• Pneumococcal polysaccharide vaccination and higher vaccination counts (pneumonia, flu) were associated with lower odds of developing Alzheimer's disease.
• This protective association was observed specifically in individuals carrying the 'A' allele of the rs6859 polymorphism.
• No significant association was found in non-carriers of the rs6859 A allele.

Outlook:

• Pneumococcal polysaccharide vaccine shows promise as a candidate for genotype-tailored Alzheimer's disease prevention.
• Further research is warranted to confirm these findings and explore underlying mechanisms.
• Personalized vaccination strategies based on genetic risk factors could revolutionize AD prevention.